MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
NVIDIA
NVDA
Tesla
TSLA
US Stock MarketDetailed Quotes
GLUE Monte Rosa Therapeutics
- 5.655
- -0.105-1.82%
Close Jan 17 16:00 ET
347.42MMarket Cap-3.18P/E (TTM)
5.910High5.550Low631.11KVolume5.790Open5.760Pre Close3.59MTurnover1.71%Turnover RatioLossP/E (Static)61.44MShares12.40052wk High1.69P/B208.86MFloat Cap3.21052wk Low--Dividend TTM36.93MShs Float45.560Historical High--Div YieldTTM6.25%Amplitude2.440Historical Low5.690Avg Price1Lot Size
Monte Rosa Therapeutics News
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townson Sharon
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warmuth Markus
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Champoux Jennifer
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Janku Filip
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dunn Edmund
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nickson Philip
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hughes Eric A
Monte Rosa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hughes Eric A
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.8%)
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(8.312%),Abigail P. Johnson(8.312%)
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(8.3%),Versant Ventures VI GP, L.P.(8.3%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Janku Filip
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ali Behbahani(12.7%),New Enterprise Associates 17, L.P.(12.5%), etc.
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(11.1%),Versant Ventures VI GP, L.P.(11.1%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dunn Edmund
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.